Craft

Nipro

Stock Price

¥1.4 K

2024-10-29

Market Capitalization

¥229.9 B

2024-10-29

Revenue

¥586.8 B

FY, 2024

Nipro Summary

Company Summary

Overview
Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business. It offers disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell culture products. The company also provides double bags, pre-filled syringes, half-type kits, glass molding vials, ampoules, cartridges, etc.
Type
Public
Status
Active
Founded
1954
HQ
Settsu, JP | view all locations
Website
https://www.nipro.co.jp
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Sano Yoshihiko

    Sano Yoshihiko, President

    • Yoshioka Kiyotaka, Managing Director

      • Masuda Toshiaki, Managing Director

        • Kobayashi Kyoetsu, Managing Director

          Operating MetricsView all

          Pre-filled Syringes Produced

          160M

          Y, 2020

          Poultices Produced, 10g-sheets

          390M

          Y, 2020

          Tapes Produced (Hotmelt Type), sheets

          580M

          Y, 2020

          LocationsView all

          68 locations detected

          • Settsu, Osaka HQ

            Japan

            3-26 Senriokashinmachi

          • Bedford, MA

            United States

            28 Crosby Drive, Suite 100

          • Miami, FL

            United States

            3150 NW 107th Avenue

          • Millville, NJ

            United States

            1200 North 10th Street

          • Naugatuck, CT

            United States

            195 Church St. 9th Floor

          • Vista, CA

            United States

            3720 Corporate View, Suite A

          and 62 others

          Nipro Financials

          Summary Financials

          Revenue (H1, 2025)
          ¥312.0B
          Gross profit (H1, 2025)
          ¥126.1B
          Net income (H1, 2025)
          ¥813.0M
          Cash (H1, 2025)
          ¥92.6B
          EBIT (H1, 2025)
          ¥12.6B
          Enterprise value
          $807.4B

          Footer menu